Search bioRxiv⌕ Search

Biology subjects

Pozo, S.

Publications and source records attributed to Pozo, S..

2 recordsLinked to original sources

The ALS/FTD-linked protein CHCHD10 associates with the TDP-43 C-terminal domain through a CHCH-helix interface

Aggregation and cytoplasmic mislocalization of TDP-43 are defining features of several neurodegenerative disorders including Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD). Yet the molecular interactions that regulate its transition from reversible assemblies to aggregation-prone states remain poorly understood. CHCHD10 is a mitochondrial protein genetically and pathologically linked to TDP-43 dysfunction, but the molecular basis connecting both proteins has remained unclear. Here, we combine solution Nuclear Magnetic Resonance (NMR) spectroscopy, biophysical assays and cellular imaging to characterize the interaction between human CHCHD10 and the C-terminal region of TDP-43 (TDP-43CTD). CHCHD10 comprises a dynamic N-terminal region and a folded CHCH domain that samples a reversible monomer-dimer equilibrium. Reciprocal NMR titrations show that the CHCH domain binds the conserved hydrophobic helix of TDP-43CTD through a dynamic submicromolar interaction that overlaps with self-association surfaces in both proteins. CHCHD10 alters the formation of ThT-reactive TDP-43CTD assemblies and reduces TDP-43CTD sedimentation under selected stoichiometric conditions, while itself becoming enriched in the sedimentable fraction. Equilibrium calculations, independently reproduced using a complete numerical mass-balance solution, identify the initial non-homodimeric CHCHD10 population as the strongest predictor of its subsequent sedimentation. In cells, full-length CHCHD10 shows stronger CHCH-dependent spatial association with TDP-43 than a construct lacking the CHCH domain. These findings define a CHCH-helix interface that couples homo- and heterotypic assembly equilibria and support an asymmetric interface-buffering model in which CHCHD10 can divert TDP-43CTD from self-association while increasing its own availability for recruitment into sedimentable assemblies.

neuroscience↗

USP29 is a novel non-canonical Hypoxia Inducible Factor-α activator

Hypoxia Inducible Factor (HIF) is the master transcriptional regulator that orchestrates cellular adaptation to low oxygen. HIF is tightly regulated via the stability of its -subunit, which is subjected to oxygen-dependent proline hydroxylation by Prolyl-Hydroxylase Domain containing proteins (PHDs/EGLNs), and ultimately targeted for proteasomal degradation through poly-ubiquitination by von-Hippel-Lindau protein (pVHL). However, sustained HIF- signalling is found in many tumours independently of oxygen availability pointing towards the relevance of non-canonical HIF- regulators. In this study, we establish the Ubiquitin Specific Protease 29 (USP29) as direct post-translational activator of HIF- in a variety of cancer cell lines. USP29 binds to HIF-, decreases poly-ubiquitination and thus protects HIF- from proteasomal degradation. Deubiquitinating activity of USP29 is essential to stabilise not only HIF-1 but also HIF-2, via their C-termini in an oxygen/PHD/pVHL-independent manner. Furthermore, in prostate cancer samples the expression of USP29 correlates with the HIF-target gene CA9 (carbonic anhydrase 9) as well as disease progression and severity.

cell biology↗